This review summarises influenza prevention and control in the context of the attenuating effects of ageing on immunity and immune response to vaccination and discusses the history and role of adjuvants in vaccine technology, with emphasis on the use of the MF59-adjuvanted vaccine to increase influenza protection in older adults. This review is sponsored by CSL Seqirus.
Please login below to download this issue (PDF)